Daiichi Sankyo To Expand European Presence With Acquisition Of 130 Merck KGaA Medical Reps
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Daiichi Sankyo's German subsidiary reached an agreement to acquire approximately 130 primary-care medical representatives now working for Merck Serono in Germany as part of the Japanese company's European business expansion, a Daiichi Sangyo spokesman
You may also be interested in...
Daiichi Sankyo Seeking Small Biotech Acquisitions In Europe
Daiichi Sankyo is scanning Europe for potential acquisitions that would help the Japanese company expand its market reach and enhance its product pipeline. Daiichi will focus on smaller biotechnology companies that have a strong oncology focus and a promising pipeline
Daiichi Sankyo Seeking Small Biotech Acquisitions In Europe
Daiichi Sankyo is scanning Europe for potential acquisitions that would help the Japanese company expand its market reach and enhance its product pipeline. Daiichi will focus on smaller biotechnology companies that have a strong oncology focus and a promising pipeline
Daiichi Sankyo Forms Ireland Marketing Subsidiary, Continues European Push
TOKYO - Daiichi Sankyo said Nov. 26 that its German subsidiary, Daiichi Sankyo Europe, has formed a sales subsidiary in Dublin, Ireland for marketing its core products by obtaining Merck Serono's cardiometabolic sales force there